Both in Pharmaceuticals
Harrow vs LB Pharmaceuticals
Over the past year HROW returned −35.1% and LBRX returned +144.6%; their daily moves had a correlation of 0.21.
HROW −35.1% LBRX +144.6%Growth of $1, one year, split-adjusted
| Metric | HROW | LBRX |
|---|---|---|
| Price | $31.40 | $37.28 |
| Market cap | $1.18B | $1.20B |
| Today | −0.63% | −1.61% |
| 1 month | −15.7% | −21.9% |
| 6 months | −5.7% | +60.3% |
| Year to date | −35.9% | +67.5% |
| 1 year | −33.3% | +141.5% |
| Revenue growth (YoY) | +10.9% | — |
| Gross margin | 71.3% | — |
| Net margin | −24.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.3× | — |
| Net cash | -$208.5M | $327.8M |
| Dividend yield | — | — |
| Volatility (60d) | 44.5% | 58.1% |
| Short % of float | 24.5% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).